Nanomics Biotechnology

Nanomics Biotech is building the world’s most integrative proteomic platform for early cancer and disease detection. Combining nanotech, automation, and AI, our fully automated system enables large-scale plasma proteome mining, powering liquid biopsy, companion diagnostics, early screening, and supporting research institutes, pharmaceutical companies, and medical enterprises.

View Site Show On Map